All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Investing in innovation: The relationship between R&D spending and financial performance in the European pharmaceutical industry

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F70883521%3A28120%2F23%3A63565518" target="_blank" >RIV/70883521:28120/23:63565518 - isvavai.cz</a>

  • Result on the web

    <a href="https://ieeca.org/journal/index.php/JEECAR/article/view/1368" target="_blank" >https://ieeca.org/journal/index.php/JEECAR/article/view/1368</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.15549/jeecar.v10i7.1368" target="_blank" >10.15549/jeecar.v10i7.1368</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Investing in innovation: The relationship between R&D spending and financial performance in the European pharmaceutical industry

  • Original language description

    The pharmaceutical industry is highly capital and knowledge-intensive, spending approximately 15% of its total revenue on research and development (R&amp;D). This study aims to find the relationship between pharmaceutical businesses&apos; financial performance and investments made in drug research and development in Europe. The study employs regression analysis with a time-lag effect of R&amp;D spending on operating earnings. It is hypothesised that the investment expenditure of the previous year’s R&amp;D investment will significantly and concurrently impact the economic-financial performance of the country and the findings show a strong and positive link between the previous year’s R&amp;D expenditure and the current year&apos;s operating profit in the European countries, providing convincing evidence that R&amp;D investments will pay off financially in the years ahead for the development of pharmaceuticals. The study also conducted diagnosis tests for the validation of the estimated models.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

  • OECD FORD branch

    50204 - Business and management

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Eastern European and Central Asian Research

  • ISSN

    2328-8272

  • e-ISSN

    2328-8280

  • Volume of the periodical

    10

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    21

  • Pages from-to

    10006-1026

  • UT code for WoS article

    001124558100001

  • EID of the result in the Scopus database

    2-s2.0-85179948358